Omega Diagnostics Group PLC
30 August 2007
30 August 2007
Omega Diagnostics Group plc
Results of Extraordinary General Meeting
Omega Diagnostics Group plc announces that at the Extraordinary General Meeting
of the company held today, all resolutions were duly passed.
Applications have been made to admit 14,875,693 New Ordinary Shares to trading
on AIM. It is expected that admission for 9,684,470 New Ordinary Shares becomes
effective on 31 August 2007 (the First Admission Shares) and that admission for
5,191,223 New Ordinary Shares becomes effective on 03 September 2007 (the Second
Admission Shares). Following the Second Admission the Company's issued share
capital will consist of 14,875,693 New Ordinary Shares with a nominal value of 4
pence each.
Following the capital reorganization and consolidation admission to AIM and
trading in the 123,245,615 Existing Ordinary Shares of 1 pence each will be
cancelled after 30 August 2007 and trading in the New Ordinary Shares of 4 pence
each will commence on 31 August 2007.
Contacts:
Omega Diagnostics Group PLC
Tel: 01259 763030
Andrew Shepherd, Chief Executive
Kieron Harbinson, Finance Director
www.omegadiagnostics.com
Landsbanki Securities (UK) Limited
Nominated Adviser & Broker
Tel: 020 7426 9000
Thilo Hoffmann/Simon Brown, Corporate Finance
Parkgreen Communications Limited
Ben Knowles
T. 020 7479 7933
Mob. 07900 346 978
Ben.knowles@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.